SFG
ABBV icon

Sather Financial Group’s AbbVie ABBV Stock Holding History

Sather Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$822K Hold
3,143
– – 0.05% 49
2026
Q2 		$791K Buy
3,143
+42
+1% +$9.04K 0.05% 51
2026
Q1 		$674K Sell
3,101
-48
-2% -$10.6K 0.04% 55
2025
Q4 		$720K Buy
3,149
+55
+2% +$12.5K 0.04% 53
2025
Q3 		$716K Buy
3,094
+332
+12% +$67.6K 0.04% 52
2025
Q2 		$513K Buy
+2,762
New +$513K 0.03% 65
2024
Q2 		– Sell
-2,769
Closed -$504K – 84
2024
Q1 		$504K Sell
2,769
-56,790
-95% -$9.8M 0.04% 57
2023
Q4 		$9.23M Buy
59,559
+156
+0.3% +$22.7K 0.68% 29
2023
Q3 		$8.85M Buy
59,403
+613
+1% +$90K 0.74% 29
2023
Q2 		$7.92M Hold
58,790
– – 0.63% 33
2023
Q1 		$9.37M Hold
58,790
– – 0.81% 31
2022
Q4 		$9.5M Buy
58,790
+56,777
+2,821% +$8.71M 0.78% 35
2022
Q3 		$270K Buy
2,013
+13
+0.7% +$1.86K 0.03% 66
2022
Q2 		$306K Hold
2,000
– – 0.03% 66
2022
Q1 		$324K Buy
+2,000
New +$291K 0.03% 70
2020
Q1 		– Sell
-3,481
Closed -$308K – 61
2019
Q4 		$308K Buy
3,481
+381
+12% +$31.6K 0.05% 63
2019
Q3 		$234K Hold
3,100
– – 0.04% 52
2019
Q2 		$225K Hold
3,100
– – 0.04% 52
2019
Q1 		$249K Hold
3,100
– – 0.05% 49
2018
Q4 		$285K Hold
3,100
– – 0.06% 52
2018
Q3 		$293K Sell
3,100
-3,000
-49% -$284K 0.06% 51
2018
Q2 		$565K Buy
6,100
+100
+2% +$9.8K 0.13% 50
2018
Q1 		$568K Hold
6,000
– – 0.13% 49
2017
Q4 		$580K Hold
6,000
– – 0.14% 44
2017
Q3 		$533K Hold
6,000
– – 0.15% 45
2017
Q2 		$435K Buy
+6,000
New +$403K 0.13% 48

Other funds holding ABBV

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Sather Financial Group's ABBV Position: Q3 2026 in Review

Sather Financial Group held its AbbVie (ABBV) position steady in Q3 2026 at 3,143 shares worth $822K. The position accounts for 0.05% of the portfolio, ranked #49.

Sather Financial Group first reported a position in ABBV in Q2 2017 and has held it in 26 quarters since. The position peaked at $9.5M in Q4 2022. 2,902 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Sather Financial Group held 3,143 shares of AbbVie worth $822K as of Q3 2026.
  • Sather Financial Group left its AbbVie share count unchanged in Q3 2026.
  • AbbVie made up 0.05% of Sather Financial Group's portfolio in Q3 2026, its #49 holding.
  • Sather Financial Group first reported a position in AbbVie in Q2 2017 and has held it in 26 quarters since.
  • Sather Financial Group's AbbVie position peaked at $9.5M in Q4 2022.
  • 2,902 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Sather Financial Group's 13F filing for Q3 2026, filed 30 Oct 2026.